Precision Therapeutics, Inc. Release: Four Abstracts on ChemoFx® to Be Presented at IGCS Annual Meeting

PITTSBURGH--(BUSINESS WIRE)--Precision Therapeutics announces that four abstracts on the ChemoFx® in vitro drug response marker have been accepted for poster presentation at the International Gynecologic Cancer Society (IGCS) Annual Meeting, which will be held in Vancouver October 13-16, 2012.

MORE ON THIS TOPIC